The adrenergic receptor antagonist carvedilol interacts with serotonin 2A receptors both in vitro and in vivo.
Adrenergic Antagonists
/ administration & dosage
Amphetamines
/ administration & dosage
Animals
Behavior, Animal
/ drug effects
Binding Sites
Carvedilol
/ administration & dosage
Computational Chemistry
/ methods
Drug Discovery
/ methods
Fluorobenzenes
/ pharmacology
HEK293 Cells
Humans
Lysergic Acid Diethylamide
/ chemistry
Male
Mice
Models, Animal
Models, Molecular
Piperidines
/ pharmacology
Protein Binding
Receptor, Serotonin, 5-HT2A
/ chemistry
Serotonin 5-HT2 Receptor Antagonists
/ pharmacology
Serotonin Receptor Agonists
/ administration & dosage
Transfection
5-HT(2A)
Carvedilol
Pharmacophore
Psychedelic
Journal
Pharmacology, biochemistry, and behavior
ISSN: 1873-5177
Titre abrégé: Pharmacol Biochem Behav
Pays: United States
ID NLM: 0367050
Informations de publication
Date de publication:
06 2019
06 2019
Historique:
received:
26
10
2018
revised:
08
03
2019
accepted:
12
04
2019
pubmed:
19
4
2019
medline:
26
2
2020
entrez:
19
4
2019
Statut:
ppublish
Résumé
There is increasing support for the potential clinical use of compounds that interact with serotonin 2A (5-HT
Identifiants
pubmed: 30998954
pii: S0091-3057(18)30561-6
doi: 10.1016/j.pbb.2019.04.003
pmc: PMC6570414
mid: NIHMS1528015
pii:
doi:
Substances chimiques
Adrenergic Antagonists
0
Amphetamines
0
Fluorobenzenes
0
Piperidines
0
Receptor, Serotonin, 5-HT2A
0
Serotonin 5-HT2 Receptor Antagonists
0
Serotonin Receptor Agonists
0
Carvedilol
0K47UL67F2
Lysergic Acid Diethylamide
8NA5SWF92O
volinanserin
EW71EE171J
4-iodo-2,5-dimethoxyphenylisopropylamine
OOM10GW9UE
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, N.I.H., Intramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
37-45Subventions
Organisme : NIDA NIH HHS
ID : R21 DA040907
Pays : United States
Organisme : NINDS NIH HHS
ID : R21 NS100512
Pays : United States
Informations de copyright
Copyright © 2019 Elsevier Inc. All rights reserved.
Références
Alcohol. 2008 Mar;42(2):91-7
pubmed: 18358987
Brain Res Mol Brain Res. 1994 Apr;23(1-2):163-78
pubmed: 8028479
J Psychopharmacol. 2014 Nov;28(11):983-92
pubmed: 25213996
Biochem Pharmacol. 2007 Jun 30;74(1):64-73
pubmed: 17451656
Naunyn Schmiedebergs Arch Pharmacol. 1982 Dec;321(4):265-70
pubmed: 6132341
Can J Psychiatry. 2005 Jun;50(7):381-8
pubmed: 16086535
Drug Alcohol Depend. 2006 Jan 4;81(1):27-36
pubmed: 15975736
Pharmacol Biochem Behav. 2014 Sep;124:260-8
pubmed: 24999220
Horm Behav. 2019 Feb;108:20-29
pubmed: 30593782
Proc Natl Acad Sci U S A. 1998 Jan 20;95(2):735-40
pubmed: 9435262
J Psychopharmacol. 2016 Dec;30(12):1181-1197
pubmed: 27909165
Alcohol Clin Exp Res. 2012 Sep;36(9):1587-99
pubmed: 22413959
Psychopharmacology (Berl). 2012 Apr;220(3):495-508
pubmed: 21993877
Alcohol Clin Exp Res. 2012 May;36(5):881-6
pubmed: 21981346
Pharmacol Biochem Behav. 2009 Jul;93(1):67-74
pubmed: 19376153
Eur Neuropsychopharmacol. 2017 Apr;27(4):383-398
pubmed: 28283227
Neuropharmacology. 1982 Jun;21(6):507-10
pubmed: 6125909
Neuropharmacology. 1997 Apr-May;36(4-5):621-9
pubmed: 9225287
Prog Neuropsychopharmacol Biol Psychiatry. 2004 May;28(3):547-57
pubmed: 15093963
J Pharmacol Exp Ther. 2010 Dec;335(3):728-34
pubmed: 20858706
Int J Quantum Chem. 2012 Dec 15;112(24):3807-3814
pubmed: 23913978
J Neurochem. 2008 Jul;106(1):244-57
pubmed: 18363829
Am J Psychother. 1986 Jul;40(3):393-404
pubmed: 2876654
Eur J Neurosci. 2004 Dec;20(11):3073-84
pubmed: 15579162
Eur Neuropsychopharmacol. 2016 Apr;26(4):756-66
pubmed: 26875114
Eur J Pharmacol. 2019 Jan 5;842:255-261
pubmed: 30412729
J Psychoactive Drugs. 1998 Oct-Dec;30(4):381-418
pubmed: 9924844
Neuron. 2007 Feb 1;53(3):439-52
pubmed: 17270739
Brain Res. 2000 Jan 24;853(2):377-80
pubmed: 10640637
Psychopharmacology (Berl). 2015 Aug;232(15):2647-57
pubmed: 25743758
Int Pharmacopsychiatry. 1971;6(4):223-35
pubmed: 4950565
Curr Med Chem. 2009;16(8):1017-27
pubmed: 19275609
J Pharmacol Exp Ther. 2004 Oct;311(1):274-81
pubmed: 15169829
Biochem Biophys Res Commun. 2010 Jun 11;396(4):1030-5
pubmed: 20471368
J Basic Clin Pharm. 2016 Mar;7(2):27-31
pubmed: 27057123
Handb Exp Pharmacol. 2018;252:227-260
pubmed: 29532180
Behav Pharmacol. 2019 Apr;30(2 and 3-Spec Issue):151-162
pubmed: 30632995
Neuropharmacology. 1997 Apr-May;36(4-5):609-20
pubmed: 9225286
Alcohol Clin Exp Res. 2014 Jun;38(6):1532-9
pubmed: 24891220
Brain Res. 1981 Mar 16;208(2):339-47
pubmed: 7214150
Prog Neuropsychopharmacol Biol Psychiatry. 2013 Jul 1;44:64-72
pubmed: 23380172
Psychopharmacology (Berl). 2019 Mar;236(3):1107-1117
pubmed: 30276421
Pharmacol Biochem Behav. 2007 Nov;88(1):18-27
pubmed: 17651790
Am J Drug Alcohol Abuse. 2017 Jan;43(1):55-60
pubmed: 27441452
Prog Neuropsychopharmacol Biol Psychiatry. 2016 Jan 4;64:250-8
pubmed: 25784600
J Psychopharmacol. 2015 Mar;29(3):289-99
pubmed: 25586396
Alcohol Clin Exp Res. 2010 Feb;34(2):223-30
pubmed: 19951299
J Pharmacol Exp Ther. 2009 Nov;331(2):717-23
pubmed: 19684254
Chem Biol Drug Des. 2006 May;67(5):370-2
pubmed: 16784462
Biochem Pharmacol. 2008 Jan 1;75(1):17-33
pubmed: 17977517
Prog Brain Res. 2018;242:25-67
pubmed: 30471682
Pharmacol Biochem Behav. 1991 Feb;38(2):353-7
pubmed: 1676173
Psychopharmacology (Berl). 1989;98(4):495-9
pubmed: 2505289
Biochem Pharmacol. 2017 Dec 15;146:139-150
pubmed: 28943238
Biochem Pharmacol. 1973 Dec 1;22(23):3099-108
pubmed: 4202581
Biomed Pharmacother. 1992;46(9):419-24
pubmed: 1363375
Front Pharmacol. 2018 Feb 08;9:89
pubmed: 29472863
J Neurochem. 2003 Aug;86(4):980-91
pubmed: 12887695
J Pharmacol Exp Ther. 2003 Jan;304(1):229-37
pubmed: 12490596
J Sleep Res. 2013 Oct;22(5):581-8
pubmed: 23879373
Naunyn Schmiedebergs Arch Pharmacol. 2009 May;379(5):461-71
pubmed: 19057895
Drug Alcohol Depend. 2003 Oct 24;72(1):33-44
pubmed: 14563541
J Neurosci. 2013 Aug 14;33(33):13367-74
pubmed: 23946394